logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12564659 B1

PDFFull Text
Date of Patent:
Mar. 03, 2026

Filed:

Apr. 20, 2018

Implantable scaffolds for treatment of sinusitis

Applicant:

Lyra Therapeutics, Inc., Watertown, MA (US);

Inventors:

Changcheng You, Northbridge, MA (US);

Quynh Pham, Methuen, MA (US);

Danny Concagh, Medfield, MA (US);

Assignee:

LYRA THERAPEUTICS, INC., Watertown, MA (US);

Attorney:

Medlen & Carroll, LLP

Primary Examiner:

Andrew J Bowman

Int. Cl.
CPC ...
A61L 27/34 (2006.01); A61F 2/18 (2006.01); A61F 2/90 (2013.01); A61K 31/58 (2006.01); A61L 27/18 (2006.01); A61L 27/54 (2006.01); A61L 27/56 (2006.01); A61L 27/58 (2006.01); A61M 25/10 (2013.01); A61M 31/00 (2006.01);
U.S. Cl.
CPC ...
A61L 27/34 (2013.01); A61F 2/186 (2013.01); A61F 2/90 (2013.01); A61K 31/58 (2013.01); A61L 27/18 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); A61L 27/58 (2013.01); A61M 25/10 (2013.01); A61M 31/002 (2013.01); A61F 2210/0004 (2013.01); A61F 2250/0031 (2013.01); A61F 2250/0067 (2013.01); A61L 2300/222 (2013.01); A61L 2300/41 (2013.01); A61L 2300/604 (2013.01); A61L 2300/608 (2013.01); A61M 2025/105 (2013.01); A61M 2210/0681 (2013.01);
Abstract

This disclosure describes, inter alia, materials, devices, kits and methods that may be used to treat chronic sinusitis. An implant is configured to fit inside of the middle meatus of a human nasal cavity. The implant includes a therapeutic-agent formulation containing a layer of over 2000 micrograms of mometasone furoate. The implant releases the mometasone furoate for more than 12 weeks. A second implant can also be provided configured to fit inside the middle meatus. The second implant also includes a therapeutic-agent formulation containing a layer of over 2000 micrograms of mometasone furoate, and releases the mometasone furoate for more than 12 weeks.

Find Patent Forward Citations

You, Changcheng. (2026). Implantable scaffolds for treatment of sinusitis (U.S. Patent No. 12564659). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12564659

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…